Anti-Leucine-Rich, Glioma-Inactivated Protein 1 (LGI1), Serum

CPT: 86255
Print Share

Special Instructions

If reflex test is performed, additional charges/CPT code(s) may apply.


Expected Turnaround Time

3 - 5 days


Related Documents


Specimen Requirements


Specimen

Serum


Volume

2 mL


Minimum Volume

1 mL


Container

Gel-barrier tube, red-top tube, serum gel tube, serum transfer tube


Storage Instructions

Room temperature


Stability Requirements

Temperature

Period

Room temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/thaw cycles

Stable x3


Causes for Rejection

CSF or plasma; contaminated, hemolyzed, or severely lipemic specimens


Test Details


Use

Leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis is a rare autoimmune voltage-gated potassium channel complex (VGKC) antibody-associated limbic encephalitis. Specifically, it is classified as an ant neuronal surface antigen- or ant synaptic protein-associated autoimmune encephalitis. In addition to the common symptoms of limbic encephalitis such as cognitive impairment, seizures, and psychiatric disorders, this disease is also associated with faciobrachial dystonic seizure (FBDA) and refractory hyponatremia. Unlike other limbic encephalirides, LGI1 antibody encephalitis is rarly accompanied by tumors and shows a good response to immunotherapy.

This test works as an aid in the diagnosis of LGI1 antibody disorders. This test is also useful in managing antibody-positive (LGI1) individual following immunotherapy and/or plasmapheresis.

This indirect fluorescent antibody assay utilizes LGI1 transfected cell lines for the detection and semi-quantification of the LGI1 IgG antibody.


Limitations

Results should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

Immunofluorescence (IFA)


References

Bing-Lei W, Jia-Hua Z, Yan L, et al. Three cases of antibody-LGI1 limbic encephalitis and review of literature. Int J Neurosci. 2019 Jul;129(7):642-648.30112956
Michael S, Waters P, Irani SR. Stop testing for auto-antibodies to the VGKC-complex: only request LGI1 and CASPR2. Pract Neurol. 2020 Oct;20(5):377-384.32595134
van Sonderen A, Petit-Pedrol M, Dalmu J, Titulaer MJ. The value of LGI1, CASPR2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017 May;13(5):290-301.28418022
Zuliani L, Nosadini M, Gastaldi M, et al. Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci. 2019 Oct;40(10):2017-2030.31161339

LOINC® Map

Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
505355 Anti-LGI1, Serum 94288-8 505356 LGI1 Antibody, Cell-based IFA 82978-8
Reflex Table for LGI1 Antibody, Cell-based IFA
Order Code Order Name Result Code Result Name UofM Result LOINC
Reflex 1 505357 Anti-LGI1 Antibody Titer,Serum 505357 Anti-LGI1 Antibody Titer,Serum 90831-9

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf